Cargando…

GUCY2C-directed CAR-T cells oppose colorectal cancer metastases without autoimmunity

Adoptive T-cell therapy (ACT) is an emerging paradigm in which T cells are genetically modified to target cancer-associated antigens and eradicate tumors. However, challenges treating epithelial cancers with ACT reflect antigen targets that are not tumor-specific, permitting immune damage to normal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Magee, Michael S., Kraft, Crystal L., Abraham, Tara S., Baybutt, Trevor R., Marszalowicz, Glen P., Li, Peng, Waldman, Scott A., Snook, Adam E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087292/ https://www.ncbi.nlm.nih.gov/pubmed/27853651 http://dx.doi.org/10.1080/2162402X.2016.1227897

Ejemplares similares

GUCY2C lysosomotropic endocytosis delivers immunotoxin therapy to metastatic colorectal cancer
por: Marszalowicz, Glen P., et al.
Publicado: (2014)

GUCY2C-targeted chimeric antigen receptor expressing T cells extend survival in a therapeutic mouse model of metastatic colorectal cancer
por: Magee, Michael S, et al.
Publicado: (2013)

GUCY2C maintains intestinal LGR5(+) stem cells by opposing ER stress
por: Kraft, Crystal L., et al.
Publicado: (2017)

Split tolerance permits safe Ad5-GUCY2C-PADRE vaccine-induced T-cell responses in colon cancer patients
por: Snook, Adam E., et al.
Publicado: (2019)

Chimeric Ad5.F35 vector evades anti-adenovirus serotype 5 neutralization opposing GUCY2C-targeted antitumor immunity
por: Flickinger Jr, John C, et al.
Publicado: (2020)

GUCY2C Opposes Systemic Genotoxic Tumorigenesis by Regulating AKT-Dependent Intestinal Barrier Integrity
por: Lin, Jieru Egeria, et al.
Publicado: (2012)

A Phase I study of AD5-GUCY2C-PADRE in stage I and II colon cancer patients
por: Snook, Adam, et al.
Publicado: (2015)

GUCY2C at the intersection of obesity and colorectal cancer
por: Waldman, Scott A, et al.
Publicado: (2013)

Hormone suppression silencing GUCY2C is required for colorectal cancer
por: Waldman, Scott A
Publicado: (2015)

GUCY2C signaling limits dopaminergic neuron vulnerability to toxic insults
por: Cheslow, Lara, et al.
Publicado: (2023)

Intestinal neuropod cell GUCY2C regulates visceral pain
por: Barton, Joshua R., et al.
Publicado: (2023)

ST-Producing E. coli Oppose Carcinogen-Induced Colorectal Tumorigenesis in Mice
por: Li, Peng, et al.
Publicado: (2017)

Silencing the intestinal GUCY2C tumor suppressor axis requires APC loss of heterozygosity
por: Pattison, Amanda M., et al.
Publicado: (2020)

Bacterial Heat-Stable Enterotoxins: Translation of Pathogenic Peptides into Novel Targeted Diagnostics and Therapeutics
por: Lin, Jieru E., et al.
Publicado: (2010)

APC-β-catenin-TCF signaling silences the intestinal guanylin-GUCY2C tumor suppressor axis
por: Blomain, Erik S., et al.
Publicado: (2020)

A β-Catenin-TCF-Sensitive Locus Control Region Mediates GUCY2C Ligand Loss in Colorectal Cancer
por: Rappaport, Jeffrey A., et al.
Publicado: (2021)

The Heat-Stable Enterotoxin Receptor, Guanylyl Cyclase C, as a Pharmacological Target in Colorectal Cancer Immunotherapy: A Bench-to-Bedside Current Report
por: Baybutt, Trevor R., et al.
Publicado: (2017)

Molecular insights into recognition of GUCY2C by T-cell engaging bispecific antibody anti-GUCY2CxCD3
por: Rampuria, Pragya, et al.
Publicado: (2023)

Opposing T Cell Responses in Experimental Autoimmune Encephalomyelitis
por: Saligrama, Naresha, et al.
Publicado: (2019)

Synergistic DNA-adenovirus prime-boost immunization eliminates metastatic colorectal cancer by inducing high avidity effector CD8+ T cells
por: Xiang, Bo, et al.
Publicado: (2014)

Congenital secretory diarrhoea caused by activating germline mutations in GUCY2C
por: Müller, Thomas, et al.
Publicado: (2016)

Prolonged intestinal transit and diarrhea in patients with an activating GUCY2C mutation
por: von Volkmann, Hilde L., et al.
Publicado: (2017)

SELL and GUCY1A1 Gene Polymorphisms in Patients with Unstable Angina
por: Malinowski, Damian, et al.
Publicado: (2022)

Functional evaluation of GUCY1A3 mutations associated with myocardial infarction risk
por: Wobst, Jana, et al.
Publicado: (2015)

Overexpression of GUCY1A2 Correlates With Poor Prognosis in Gastric Cancer Patients
por: Li, Xin, et al.
Publicado: (2021)

A novel GUCY2D mutation in a Chinese family with dominant cone dystrophy
por: Zhao, Xin, et al.
Publicado: (2013)

Novel GUCY2D Gene Mutations in Japanese Male Twins with Leber Congenital Amaurosis
por: Hosono, Katsuhiro, et al.
Publicado: (2015)

A Potential Treatment of Congenital Sodium Diarrhea in Patients With Activating GUCY2C Mutations
por: van Vugt, Anke H.M., et al.
Publicado: (2021)

Loss of TIPE2 Has Opposing Effects on the Pathogenesis of Autoimmune Diseases
por: Liu, Ruiling, et al.
Publicado: (2019)

The Guanylate Cyclase C—cGMP Signaling Axis Opposes Intestinal Epithelial Injury and Neoplasia
por: Rappaport, Jeffrey A., et al.
Publicado: (2018)

CAR T cells for treating autoimmune diseases
por: Blache, Ulrich, et al.
Publicado: (2023)

Chimeric adenoviral (Ad5.F35) and listeria vector prime-boost immunization is safe and effective for cancer immunotherapy
por: Flickinger, John C., et al.
Publicado: (2022)

Preclinical studies in support of phase I/II clinical trials to treat GUCY2D-associated Leber congenital amaurosis
por: Boye, Sanford L., et al.
Publicado: (2022)

Postretinal Structure and Function in Severe Congenital Photoreceptor Blindness Caused by Mutations in the GUCY2D Gene
por: Aguirre, Geoffrey K., et al.
Publicado: (2017)

A natural history study of autosomal dominant GUCY2D-associated cone–rod dystrophy
por: Scopelliti, Amanda J., et al.
Publicado: (2023)

Opposing Roles of Interferon-Gamma on Cells of the Central Nervous System in Autoimmune Neuroinflammation
por: Ottum, Payton A., et al.
Publicado: (2015)

Targeting Opposing Immunological Roles of the Junctional Adhesion Molecule-A in Autoimmunity and Cancer
por: Bonilha, Caio S., et al.
Publicado: (2020)

A recurrent mutation in GUCY2D associated with autosomal dominant cone dystrophy in a Chinese family
por: Xiao, Xueshan, et al.
Publicado: (2011)

Novel GUCY2D mutation causes phenotypic variability of Leber congenital amaurosis in a large kindred
por: Gradstein, Libe, et al.
Publicado: (2016)

The pathogenicity of novel GUCY2D mutations in Leber congenital amaurosis 1 assessed by HPLC-MS/MS
por: Feng, Xue, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b4n33k2bk17ftgatbjk39j194l